Xcout Intel
Spot Biosystems
Spot Biosystems is a gene therapy company pioneering a novel non-viral extracellular delivery approach. Headquartered in Palo Alto, California, the company launched with significant financing to advance its therapeutic pipeline.
Subscribe to see Spot Biosystems’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Spot Biosystems at a glance
Spot Biosystems is a healthcare company headquartered in United States. Its most recent funding round, Series A, raised $40M in June 2026. Xcout tracks 1 named person at Spot Biosystems, including Andrew Lee (Co-Founder).
Spot Biosystems leadership
- Andrew LeeCo-Founder
Spot Biosystems funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $40M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Spot Biosystems competitors
A few of Spot Biosystems's closest competitors — see the full list of competitors and alternatives →
GenEdit is a South San Francisco, California-based startup developing alternative methods of delivering gene-based and CRISPR-based medicines.
GEn1E Lifesciences Inc. is a clinical-stage, Phase 2 biotechnology research company based in Palo Alto, California, focused on accelerating novel precision therapies.
GEMMABio is a privately held therapeutics company founded in 2024 in Philadelphia, Pennsylvania, dedicated to developing novel gene therapies for rare diseases.
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California, and Durham, North Carolina. The company leverages proprietary delivery systems to power a new class of disease-modifying genetic therapies.
Get Spot Biosystems's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Spot Biosystems in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access